15 May 2025 in World Neurosurgery
GKGayrat Maratovich Kariev
+3
There are a variety of complications of endoscopic third ventriculostomy (ETV) that have been described in the literature. Cerebrospinal fluid leak is one of the common complications that need to be addressed properly and timely management plays a crucial role in prevention of meningitis/encephalitis. To share our experience of using autologous bone (from burr hole) debris and "BloodSTOP" absorbable hemostatic agent as an effective tool in cerebrospinal fluid leak prevention. We have observed 14 individuals who have undergone an ETV procedure using the abovementioned multilayered technique of burr hole closure at our institution in 2024. A watertight dural closure is a mandatory step in every case of neurosurgical procedure. But when primary dural closure is not possible in endoscopic intraventricular surgeries, there is a way out using more affordable hemostatic materials like BloodSTOP. There are plenty of strategies in surgical closure technique, including pericranial graft, dural allografts and synthetic substitutes, and various sealants but no single consensus on the best practice regarding dural closure. TachoSil is a hemostatic agent consisting of human fibrinogen and thrombin coated onto an equine collagen sponge and has proven efficacy as a sealant for easy repair of encephalocele, incidental spinal durotomy, transsphenoidal surgery, and intradural cranial and spinal lesions. We report the use of a simple novel, sutureless BloodSTOP sandwich dural closure technique for post ETV dural defects, which has proven efficacy in our study when watertight primary dural closure is not technically feasible.
22 July 2024 in Euroasian Health Journal
Цель: освещение тестовой системы, оценивающую речевую деятельность пациентов с различными патологическими состояниями, включая опухоли головного мозга, расположенными в функционально важных центрах головного мозга, а именно в речевом центре, до, во время и в послеоперационном периоде. Материал и методы. Тест был апробирован на 25 здоровых лицах и с 2024 года также был протестирован на пациентах, перенесших хирургическое лечение глиом полушарий головного мозга доминантного полушария в отделении хирургии основании черепа. Результаты. Узбекский тест афазии успешно был апробирован у 25 здоровых лиц и был рекомендован к внедрению в клинико-неврологическую диагностическую практику в нейрохирургии и в неврологии. Вывод. Узбекский нейролингвистический тест служит удобным речевым протоколом для оценки речевой функции пациентов. Тест позволяет мониторировать речевую деятельность пациентов как до, так и интра/послеоперационном периоде, своевременно выявлять функциональный дефицит. Purpose: to enlighten about first Uzbek aphasia testing system that helps to assess the speech disorders in patients who had surgical resection of the tumors of eloquent brain areas of the brain, furthermore in patients with various pathological conditions, including ischemic stroke of eloquent areas. Materials and methods. The linguistic protocol was tested on 25 healthy individuals, and on patients of the institution's skull base surgery department. Results. Uzbek Aphasia Test has been validated by testing on 25 healthy individuals and recommended to use in neurological clinical examinations on patients in republican scientific center of neurosurgery. Conclusion. The Uzbek Aphasia Test System serves as a convenient speech assessment protocol not only for intraoperative settings but also postoperatively, helping to functionally evaluate the degree of damage on language cortex and subcortical language networks. Utilizing this protocol, it is possible to monitor the neurological status of patients also in the postoperative period, this, in turn, reduces chances of disabilities caused by intraoperative damage to eloquent language areas.